Home › Funds › Two Sigma Investments › PHIO
Two Sigma Investments position in PHIO
PHIO PHARMACEUTICALS CORP · Health Care
Latest position (Q2 2026)21.50K sh
Reported value held$22.04K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 42.14K | $86.00K | New |
| Q4 2021 | 128.72K | $129.00K | Add |
| Q2 2022 | 27.79K | $20.00K | New |
| Q3 2022 | 23.20K | $13.00K | Reduce |
| Q4 2022 | 22.40K | $8.33K | Reduce |
| Q4 2025 | 14.49K | $15.22K | New |
| Q1 2026 | 32.49K | $39.64K | Add |
| Q2 2026 | 21.50K | $22.04K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PHIO
- Geode Capital Management 114.57K sh · $117.44K · Q2 2026
- Vanguard Group 87.63K sh · $92.01K · Q4 2025
- Citadel Advisors 47.15K sh · $48.33K · Q2 2026
- Northern Trust Corp 27.77K sh · $28.46K · Q2 2026
- Citigroup Inc 11.61K sh · $11.89K · Q2 2026
- Morgan Stanley 6.00K sh · $6.15K · Q2 2026
- UBS Group AG 5.39K sh · $5.52K · Q2 2026